Mediplantex National Pharmaceutical JSC
VN:MED
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| VN |
M
|
Mediplantex National Pharmaceutical JSC
VN:MED
|
345B VND |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
564.7B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
287.9B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.9B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
229.6B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215B GBP |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
153.2B USD |
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
98.9B EUR |
Loading...
|
Market Distribution
| Min | -67 046.2% |
| 30th Percentile | 1.4% |
| Median | 4% |
| 70th Percentile | 9.8% |
| Max | 1 155.9% |
Other Profitability Ratios
Mediplantex National Pharmaceutical JSC
Glance View
Mediplantex National Pharmaceutical JSC engages in the manufacture and sale of pharmaceutical products and raw materials. The company is headquartered in Hanoi, Hanoi. The company went IPO on 2020-03-18. The firm is engaged in the manufacturing of pharmaceutical products, including various types of pharmaceutical preparations and medicinal and botanical preparations, as well as herb farming. Besides, it is involved in the import, export and wholesale and retail trading of pharmaceutical products through its drug stores. The firm is also investing in real estate projects so as to lease offices, apartments and warehouse.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Mediplantex National Pharmaceutical JSC is 3.2%, which is in line with its 3-year median of 3.2%.
Over the last 3 years, Mediplantex National Pharmaceutical JSC’s Net Margin has increased from -0.8% to 3.2%. During this period, it reached a low of -0.8% on May 30, 2022 and a high of 3.6% on Sep 30, 2024.
